SSTR2 and acromegaly: From a prognostic point of view, low/absent cytoplasmic SSTR2 expression is correlated with recurrence rate, reintervention probability, and poor response to somatostatin receptor ligands (SRLs) therapy in acromegaly [98,103,104].